The DOI matches its Crossref record.
Polystyrene-Poly (Ethylene Glycol) (PS-PEG2000) Particles as Model Systems for Site Specific Drug Delivery. 2. The Effect of PEG Surface Density on the in Vitro Cell Interaction and in VivoBiodistribution
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
(2015) · Springer eBooks · doi:10.1007/978-3-319-16510-3 · Cited by 3,502
Mediating Tumor Targeting Efficiency of Nanoparticles Through Design
Perrault, S. D., Walkey, C., Jennings, T., Fischer, H. C., & Chan, W. C. W. (2009) · Nano Letters · doi:10.1021/nl900031y · Cited by 1,513
Polyethylene glycol (PEG): A versatile polymer for pharmaceutical applications
D’souza, A. A., & Shegokar, R. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1182485 · Cited by 1,282
“[80] In another study, PLA nanoparticles coated with PEG 2100 also exhibited increased systemic circulation time with increase in concentration of PEG from 0% to 73%.[81] Ideally, PEG 3000 to PEG 5000 are considered during formulation of long circulating nanoparticles.”
BackgroundLetchford, K., & Burt, H. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.11.009 · Cited by 1,143
The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres
Gref, R., Domb, A., Quellec, P., Blunk, T., Müller, R. H., Verbavatz, J. M., & Langer, R. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00026-4 · Cited by 820
Poly(ethylene oxide)-block-poly(l-amino acid) micelles for drug delivery
Lavasanifar, A., Samuel, J., & Kwon, G. S. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00015-7 · Cited by 756
Parameters influencing the stealthiness of colloidal drug delivery systems
Vonarbourg, A., Passirani, C., Saulnier, P., & Benoit, J.-P. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.03.039 · Cited by 740
Polymersomes for drug delivery: Design, formation and characterization
Lee, J. S., & Feijen, J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.10.005 · Cited by 723
Long circulating microparticulate drug carriers
Stolnik, S., Illum, L., & Davis, S. S. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00025-3 · Cited by 700
Self-citationGupta, A. K., & Wells, S. (2004) · IEEE Transactions on Nanobioscience · doi:10.1109/tnb.2003.820277 · Cited by 634
Polyethylene glycol-coated biocompatible surfaces
Alcantar, N. A., Aydil, E. S., & Israelachvili, J. N. (2000) · Journal of Biomedical Materials Research · doi:10.1002/1097-4636(20000905)51:3<343::aid-jbm7>3.0.co;2-d · Cited by 634
Hydrogel-Based Controlled Drug Delivery for Cancer Treatment: A Review
Sun, Z., Song, C., Wang, C., Hu, Y., & Wu, J. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b01020 · Cited by 413
Effect of Chain Density on Inhibition of Protein Adsorption by Poly(ethylene glycol) Based Coatings
Malmsten, M., Emoto, K., & Van Alstine, J. M. (1998) · Journal of Colloid and Interface Science · doi:10.1006/jcis.1998.5513 · Cited by 342
Stealth Properties to Improve Therapeutic Efficacy of Drug Nanocarriers
Salmaso, S., & Caliceti, P. (2013) · Journal of Drug Delivery · doi:10.1155/2013/374252 · Cited by 340
Riley, T., Stolnik, S., Heald, C. R., Xiong, C. D., Garnett, M. C., Illum, L., Davis, S. S., Purkiss, S. C., Barlow, R. J., & Gellert, P. R. (2001) · Langmuir · doi:10.1021/la001226i · Cited by 306
Self-citationSources and Pathways of Microplastics to Habitats
Browne, M. A. (2015) · Marine Anthropogenic Litter · doi:10.1007/978-3-319-16510-3_9 · Cited by 272
Leroux, J.-C., Allémann, E., De Jaeghere, F., Doelker, E., & Gurny, R. (1996) · Journal of Controlled Release · doi:10.1016/0168-3659(95)00164-6 · Cited by 268
Gaur, U., Sahoo, S. K., De, T. K., Ghosh, P. C., Maitra, A., & Ghosh, P. K. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00447-0 · Cited by 267
A new approach towards acid sensitive copolymer micelles for drug delivery
Gillies, E. R., & Fréchet, J. M. J. (2003) · Chem. Commun. · doi:10.1039/b304251k · Cited by 252
Defining the drug incorporation properties of PLA–PEG nanoparticles
Govender, T. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00375-6 · Cited by 225
Vitreous: A Barrier to Nonviral Ocular Gene Therapy
Peeters, L., Sanders, N. N., Braeckmans, K., Boussery, K., Van de Voorde, J., De Smedt, S. C., & Demeester, J. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0165 · Cited by 189
Liu, J., Zeng, F., & Allen, C. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.11.010 · Cited by 183
Metadata
- Authors
- Dunn, S. E., Brindley, A., Davis, S. S., Davies, M. C., & Illum, L.
- Venue
- Pharmaceutical Research
- Published
- 1994-07
- Volume
- 11
- Issue
- 7
- Pages
- 1016-1022
- ISSN
- 0724-8741 (ISSN-L)
- 1573-904X
- OpenAlex
- W1556946350
- Cited by
- 168
- References
- 0
- FWCI
- 6.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.